Fair Value Calculator Fair Value Calculator
EN DE

Acrinova AB (ACRI-B) Fair Value & Analysis

Real Estate · SE · Market cap 321M SEK

AA Acrinova AB ACRI-B · ST
Pricekr 7.20
Fair Valuekr 18.45
Upside+156.3%
Quality53/100
Watch Acrinova AB for free, get notified when fair value or trend changes. Watch for free
Evidence: High Range kr 13.34 – kr 23.06 📤 Share as image

Fair value as of: Jul 13, 2026

From 22 valuation models · updated 9 days ago

Fair value updated Jul 13, 2026, revised from kr 18.25 to kr 18.45 (+1.1%) since Jul 7, 2026.

Price vs Fair Value (12 months)

kr 10.70 kr 6.80 Fair Value kr 18.45 Jul 2025 Jul 2026

12‑month range kr 6.80 – kr 10.70 · fair‑value band kr 13.34 – kr 23.06 · the kr 7.20 price screens below the kr 18.45 fair value. As of Jul 13, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Acrinova AB (ACRI-B) currently trades at kr 7.20, while our model-based Fair Value estimate is kr 18.45, implying the stock looks roughly 156.3% undervalued today. We read business quality at 53/100 (solid quality), in the Real Estate sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, Acrinova AB generated revenue of 128M SEK at a net margin of 46.8%. Revenue declined 68.1% year over year. It earns a return on equity of 7.9%. Net debt stands at 250M SEK. Fundamentals as of Jul 13, 2026

Our scenario range runs from kr 13.34 (bear case) to kr 23.06 (bull case); at kr 7.20, the current price sits below that range. The share trades about 35% below its 52-week high and 6% above its 52-week low, currently below its 200-day average. For context, the median of 10 Real Estate peers we cover trades at 9% fair-value upside, at 156%, ACRI-B screens cheaper than that median.

Key figures & financial health

Revenue (TTM) 101M SEK
Revenue growth (YoY) -66.3%
Net margin 37.4%
Return on equity 4.9%
Free cash flow 251M SEK FY2025
P/E ratio 11.9
More key figures
Operating margin 16.6%
EPS (TTM) kr 0.6200
EPS growth (YoY) -94.1%
Net debt 250M SEK FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 13, 2026. TTM = trailing twelve months.

About the company

Acrinova AB (publ), a real estate company, owns, develops, and manages real estate properties in Sweden. Its property portfolio includes trade and service, warehouse and production, and residential properties, as well as logistics/production, housing, shop, industrial and commercial premises, restaurant, and office. The company was incorporated in 2014 and is headquartered in Malmö, Sweden.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Acrinova AB reported revenue of kr 128M in FY2025 versus kr 102M in FY2021, a compound +5.9%/yr. Reported net income was kr 60.0M in FY2025, compounding −20.9%/yr from FY2021.

Revenue +5.9%/yr
FY21 kr 102M
FY22 kr 131M
FY23 kr 147M
FY24 kr 160M
FY25 kr 128M
Net income −20.9%/yr
FY21 kr 153M
FY22 kr 79.3M
FY23 kr 7.8M
FY24 kr 35.9M
FY25 kr 60.0M

Is ACRI-B fairly valued? → Check now

📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog, it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "Acrinova AB Fair Value". https://www.fairvalue-calculator.com/stock/ACRI-B

Similar stocks

10 more Real Estate - Diversified stocks, each showing price versus our Fair Value estimate (as of Jul 13, 2026).

Stock Price Fair Value vs Fair Value
Mitsubishi Estate Co MITEY $24.70 $13.49 -45%
Mitsui Fudosan Co MTSFF $9.40 $10.25 +9%
Henderson Land Development Company HLDVF $3.70 $2.19 -41%
Swiss Prime Site AG SPSN CHF 131.90 CHF 44.83 -66%
Central Pattana Public Company CPN 64.50 THB 79.02 THB +23%
SM Prime Holdings SPHXF $0.2801 $0.4700 +68%
Prestige Estates Projects Limited PRESTIGE ₹1,556 ₹645.21 -59%
The Phoenix Mills Limited PHOENIXLTD ₹1,751 ₹699.95 -60%
Fastighets AB BALDF $5.42 $7.00 +29%
NEPI Rockcastle N.V NRP €7.33 €10.42 +42%

Explore undervalued stocks

More undervalued Real Estate stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is Acrinova AB (ACRI-B) undervalued?
As of Jul 13, 2026, our model estimates a fair value of kr 18.45 versus a price of kr 7.20, about +156% (undervalued). Model-based estimate, not financial advice.
What is the fair value of ACRI-B?
Our model-based fair value for Acrinova AB is kr 18.45 (as of Jul 13, 2026), built from audited fundamentals. The current price is kr 7.20.
What is the quality score of ACRI-B?
Acrinova AB has a Quality Score of 53/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of Acrinova AB (ACRI-B)?
Acrinova AB reported trailing-twelve-month revenue of about 128M SEK (latest available figure, as of Jul 13, 2026).
What is the net profit margin of ACRI-B?
The net profit margin of Acrinova AB is about 46.8%, meaning it keeps roughly 46.8% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Unlock the full Acrinova AB analysis, and try Pro free

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.